HUTCHMED China (UK) Today
| HCM Stock | 276.00 6.00 2.13% |
Performance4 of 100
| Odds Of DistressLess than 20
|
HUTCHMED China is trading at 276.00 as of the 27th of November 2024, a 2.13 percent decrease since the beginning of the trading day. The stock's lowest day price was 272.36. HUTCHMED China has about a 20 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for HUTCHMED China are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of October 2024 and ending today, the 27th of November 2024. Click here to learn more.
Moving against HUTCHMED Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
HUTCHMED Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. HUTCHMED China's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding HUTCHMED China or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
HUTCHMED China (HCM) is traded on London Exchange in UK and employs 1,970 people. HUTCHMED China is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.44 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate HUTCHMED China's market, we take the total number of its shares issued and multiply it by HUTCHMED China's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. HUTCHMED China operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 854.64 M outstanding shares.
HUTCHMED China generates positive cash flow from operations, but has no cash available
Check HUTCHMED China Probability Of Bankruptcy
Ownership AllocationHUTCHMED China has a total of 854.64 Million outstanding shares. HUTCHMED China secures large amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check HUTCHMED Ownership Details
HUTCHMED China Risk Profiles
Although HUTCHMED China's alpha and beta are two of the key measurements used to evaluate HUTCHMED China's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.16 | |||
| Semi Deviation | 2.25 | |||
| Standard Deviation | 2.84 | |||
| Variance | 8.04 |
HUTCHMED Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in HUTCHMED China without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Cryptocurrency Center Now
Cryptocurrency CenterBuild and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
| All Next | Launch Module |
HUTCHMED China Corporate Management
Elected by the shareholders, the HUTCHMED China's board of directors comprises two types of representatives: HUTCHMED China inside directors who are chosen from within the company, and outside directors, selected externally and held independent of HUTCHMED. The board's role is to monitor HUTCHMED China's management team and ensure that shareholders' interests are well served. HUTCHMED China's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, HUTCHMED China's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kin MBA | Senior Communications | Profile | |
| CA BEc | CFO Director | Profile | |
| CS CGP | Company Director | Profile | |
| Yiling Cui | Executive Operations | Profile | |
| Charles Nixon | Group Counsel | Profile | |
| Qingmei Wang | Senior Alliances | Profile |
Other Information on Investing in HUTCHMED Stock
HUTCHMED China financial ratios help investors to determine whether HUTCHMED Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HUTCHMED with respect to the benefits of owning HUTCHMED China security.